Home › Funds › Stonepine Capital Management, LLC › CNTB

Stonepine Capital Management, LLC position in CNTB

CONNECT BIOPHARMA HLDGS LTD · Health Care

Stonepine Capital Management, LLC reported holding 364,254 shares of CNTB (CONNECT BIOPHARMA HLDGS LTD) in its Q2 2026 13F filing — a position valued at US$867K, representing 0.57% of its reported portfolio and ranking #44 among its reported holdings. Stonepine Capital Management, LLC has disclosed CNTB holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)364.25K sh
Reported value held$866.92K
Portfolio Weight0.57%
First reportedQ1 2026
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Stonepine Capital Management, LLC's CNTB position evolved

Stonepine Capital Management, LLC first disclosed a stake in CNTB in Q1 2026 at 310,000 shares (US$812K). The position peaked in Q2 2026 at 364,254 shares, worth US$867K. Across 2 filings, Stonepine Capital Management, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 364,254 shares valued at US$867K — an increase of 54,254 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2026 310.00K $812.20K New
Q2 2026 364.25K $866.92K Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CNTB and 13F data

CNTB (CONNECT BIOPHARMA HLDGS LTD) is a Health Care company. 62 other funds we track also report a position in CNTB — the largest reported positions include Ikarian Capital, LLC (US$10.8M), BML Capital Management, LLC (US$1.4M), Richmond Brothers, Inc. (US$1.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CNTB

All CNTB fund holders →

FAQ

How long has Stonepine Capital Management, LLC held CNTB?

Stonepine Capital Management, LLC has disclosed CNTB holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Stonepine Capital Management, LLC's current position in CNTB?

As of Q2 2026, Stonepine Capital Management, LLC holds 364.25K shares of CNTB (CONNECT BIOPHARMA HLDGS LTD), valued at $866.92K, representing 0.57% of its reported portfolio and ranking #44.

Has Stonepine Capital Management, LLC been buying or selling CNTB?

In the latest 13F filing (Q2 2026), Stonepine Capital Management, LLC increased its position in CNTB. The position peaked in Q2 2026 at 364.25K shares.

Which other funds hold CNTB?

Other major institutional holders of CNTB include Ikarian Capital, LLC, BML Capital Management, LLC, Richmond Brothers, Inc., among 62 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.